Bath Salts to Therapies : Can Separation of Adverse and Therapeutic Effects of Substituted Cathinones Lead to a Medication for Psychostimulant Use Disorder?
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:385 |
|---|---|
| Enthalten in: |
The Journal of pharmacology and experimental therapeutics - 385(2023), 3 vom: 17. Juni, Seite 159-161 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Unterwald, Ellen M [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
540EI4406J |
|---|
| Anmerkungen: |
Date Completed 19.05.2023 Date Revised 20.06.2023 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1124/jpet.123.001650 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM357005562 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM357005562 | ||
| 003 | DE-627 | ||
| 005 | 20231226071645.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1124/jpet.123.001650 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1189.xml |
| 035 | |a (DE-627)NLM357005562 | ||
| 035 | |a (NLM)37197988 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Unterwald, Ellen M |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Bath Salts to Therapies |b Can Separation of Adverse and Therapeutic Effects of Substituted Cathinones Lead to a Medication for Psychostimulant Use Disorder? |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 19.05.2023 | ||
| 500 | |a Date Revised 20.06.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a cathinone |2 NLM | |
| 650 | 7 | |a 540EI4406J |2 NLM | |
| 650 | 7 | |a Salts |2 NLM | |
| 650 | 7 | |a Central Nervous System Stimulants |2 NLM | |
| 650 | 7 | |a Alkaloids |2 NLM | |
| 650 | 7 | |a Designer Drugs |2 NLM | |
| 700 | 1 | |a Rawls, Scott M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Journal of pharmacology and experimental therapeutics |d 1945 |g 385(2023), 3 vom: 17. Juni, Seite 159-161 |w (DE-627)NLM000006475 |x 1521-0103 |7 nnns |
| 773 | 1 | 8 | |g volume:385 |g year:2023 |g number:3 |g day:17 |g month:06 |g pages:159-161 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1124/jpet.123.001650 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 385 |j 2023 |e 3 |b 17 |c 06 |h 159-161 | ||